Diabetes tech gains momentum 

More people with diabetes are moving towards wearables and virtual care, accelerated by the coronavirus pandemic, a survey conducted in the US has found.

Pump makers Insulet and Tandem have reported solid results for 2020, and both companies expect that momentum to continue, while Medtronic has a renewed focus on diabetes tech.

The survey, by SVB Leerink, reported that adoption among patients with Type 1 diabetes is projected to grow from 51% in 2021 to 62% in 2024.

SVB Leerink commissioned MEDACorp to survey 101 endocrinologists and nurse practitioners, representing 124,847 diabetes patients. The group is a global network of healthcare professionals and part of SVB Leerink.

Adoption among insulin-intensive Type 2 patients is projected to grow from 17% in 2021 to 23% in 2024.

Read more HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags